Author | Country | Design | Sample size | Follow-up Period | Female | Age Median ± IQR | CD4 count Median ± IQR | Viral load (log) Median ± IQR | BMI Median ± IQR |
---|---|---|---|---|---|---|---|---|---|
Stringer et al. [50] | Zambia and Kenya | Prospective Cohort | 509 152 | 4 years | 661 | Zambia 32 (28–36) Kenya 32 (28–36) | 148 (88–211) 147 (76.5–212.5) | 5.0 (4.4–5.4) 5.3 (4.8–5.9) | 19.7 (18.3–21.9) 19.9 (17.7–22.6) |
Kwobah et al. [51] | Kenya | Case-control | 3233 | 5 years | 1992 | Case: 36.3(30.6–43.2) Control: 36.5(30.7–43.1) | Case: 80 (32–177) Control: 194 (112–324) | NA | NA |
Nachega et al. [45] | South Africa | Cohort | 1817 | 10 years | 1771 | NVP: 33.2 (7.68) EFV: 36(8.0) | NVP: 171(78–243) EFV: 136(58–216) | NVP: 5.1(4.6–5.6) EFV: 5.2(4.7–5.7) | NA |
Boulle et al. (18, 48) | South Africa | Cohort | 2679 | 4 years | 1896 | 32(28–38) | 83(34–140) | 5.5(4.6–5.5) | NA |
Shearer et al. ([47]) | South Africa | Cohort | 12,840 | 8 years | 7962 | EFV: 37.2(31.9–43.9) NVP: 33.0(28.4–39.1) | EFV: 98(36–169) NVP: 100.5(42–160) | NA | EFV: 21.7 (19.2_24.9) NVP: 22.0 (19.7_25.1) |
Sarfo et al. [52] | Ghana | Retrospective Observational | 3990 | 7 years | 2717 | EFV: 40 (35–47) NVP: 35 (30–41) | EFV: 127 (45–213) NVP: 140 (56–220) | NA | EFV: 19.6 (17.4–22.3) NVP: 19.9 (17.6–22.9) |
Shearer et al. [46] | South Africa | Cohort | 2385 | 1 year | 1485 | EFV: 37.8 (31.8–44.3) NVP: 33.1 (28.1–40.4) | EFV: 132 (58–194) NVP: 132 (66–179) | NA | EFV: 22.5 (19.7–25.9) NVP: 23.0 (20.2–25.6) |
Barth et al. [49] | South Africa | Retrospective observational cohort | 735 | 2–4 years | 526 | Mean = 35.3 | 68 (20–140) | Mean = 4.9 | NA |
Gsponer et al. [54] | Sub-Saharan Africa | Collaborative analysis | 2404 | 6 years | 1276 | Switched: 29 (25–33) Not switched: 29 (25–34) | Switched: 77 (41–133) Not switched: 146 (82–232) | NA | NA |
Sarfo et al. [10] | Ghana | Retrospective cohort study | 3999 | 7 years | 2727 | 38 (32–45) | 132 (50–217) | NA | 19.8(17.5–22.7) |
Keiser et al. [55] | Sub-Saharan Africa | Case control | 4281 | 5 years | 3022 | Switch: 35 (30–41) Not switch: 34 (30–40) | Switch: 73 (23–133) Not switch: 67 (21–161) | Switch: 5.0 (4.4–5.6) Not switch: 5.3 (4.6–5.8) | NA |
Anlay et al. [53] | Ethiopia | Retrospective follow-up | 410 | 5 years | 265 | 33.3 ± 8.7 | 162.5 (90.5–235.5) | NA | NA |
van Zyl et al. [43] | South Africa | Retrospective | 167 | 4Â years | NA | NA | NA | NA | NA |
Abah et al. [42] | Nigeria | Cohort | 6309 | 3 years | 4156 | 35 (30–42) | 154 (76–259) | NA | NA |
Bock et al. [44] | South Africa | Multicentre cohort | 27,350 | 4 years | 16,828 | EFV: 35.8 (30.7–42.6) NVP: 31.1 (27.1–35.8) | EFV: 107 (51–160) NVP: 132 (76–177) | NA | NA |
Tirfe et al. [25] | Ethiopia | Retrospective cohort study | 492 | 3Â years | 289 | EFV: 35(10) NVP: 33(11) | NA | NA | NA |